Hangaram Investment Management Co.,Ltd acquired 5.1% stake in Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:A023910) on February 11, 2014. Hangaram Investment acquired 0.3 million shares of Daihan Pharmaceutical.
Hangaram Investment Management Co.,Ltd completed the acquisition of 5.1% stake in Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:A023910) on February 11, 2014.
DAIHAN PHARMACEUTICAL CO.,LTD. is a Korea-based company mainly engaged in the manufacture and distribution of pharmaceuticals. The Company provides infusions, including basic infusions, nutritional infusions and infusions for special uses; injections for anesthetics, vitamin-minerals, autonomic nerve systems, hypnotic-sedatives, antispasmodics, antidotes, hormones, analgesics, respiratory and others; contrast media, such as drugs for computed tomography (CT) uses and magnetic resonance imaging (MRI) uses, and other drugs, such as drugs for irrigations, ointments, inhalants, as well as quasi-drugs such as hand gels, lens clean solutions and others.